Search for the latest oncology news by tumour type
The first-in-class PARP1-selective inhibitor saruparib demonstrated encouraging early efficacy and a favourable safety profile in…
What if we could eliminate a major risk factor for stomach cancer in Black, Asian,…
A broad range of genetic and environmental factors can influence the progression of respiratory cancer,…
It is possible to leave most of the lymph nodes in the armpit, even if…
A simple urine test can more than halve the number of cystoscopies necessary to follow…
A simple blood test every five years is sufficient to screen low-risk men for prostate…
A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center (USA) investigators suggests that…
Researchers at The University of Texas MD Anderson Cancer Center, USA, showed that altering the…
In a small, investigator-initiated phase 2 study by Dana-Farber Cancer Institute investigators (USA), a novel…
The largest study to date investigating a single invitation to a PSA blood test to…